Medical Blog About Treatment Abroad

Ovarian cancer remains one of the most challenging malignancies in gynecologic oncology. Often diagnosed at an advanced stage, it is the fifth leading cause of cancer-related death among women in the Western world. According to the American Cancer Society, over 20,000 new cases of ovarian cancer will be diagnosed in the...

Stomach cancer remains a serious global health concern, with over 1 million new cases diagnosed each year and approximately 770,000 deaths worldwide. While incidence rates have been declining in some regions due to better screening and dietary changes, late diagnosis and aggressive disease progression continue to make gastric...

Bile duct cancer, also known as cholangiocarcinoma, is a malignant tumor that can originate in any part of the bile duct system. Bile duct cancer is considered to be rare as compared to other types of cancer, with less than 8,000 people diagnosed with it every year. Females are less likely to suffer from the disease than males.

Ovarian cancer is one of the most common gynecological malignancies affecting women worldwide. According to the latest statistics, ovarian cancer is the eighth most common cancer among women worldwide, with approximately 313,000 new cases diagnosed each year. Due to the lack of specific symptoms, the disease is very difficult to diagnose...

Multiple myeloma is a malignant blood disorder that affects plasma cells – white blood cells responsible for producing antibodies. This type of cancer typically develops in the bone marrow and can lead to bone damage, anemia, kidney failure, and a weakened immune system. Although it remains incurable, the last decade has brought significant...

Medulloblastoma, while most commonly associated with children, can also occur in adults, although it is much rarer. In adults, medulloblastoma accounts for less than 1% of all primary brain tumors. It typically originates in the cerebellum, which is the part of the brain responsible for balance, coordination, and motor control.

Non-small cell lung cancer affects 85% of lung cancer patients, with stage III-IV cases having less than 5% five-year survival rates. While traditional treatments help only 30% of selected patients, innovative dendritic cell immunotherapy shows 50-65% effectiveness rates in clinical studies. These "immune system generals" train your body to fight...

Pancreatic cancer stands as one of the most aggressive and lethal forms of gastrointestinal carcinoma, often diagnosed at an advanced stage. In 2022 alone, it accounted for approximately 467,000 deaths worldwide, making it the sixth leading cause of cancer-related mortality globally. The overall 5-year survival rate for pancreatic cancer remains...